Current management of peptic ulcer bleeding

被引:20
作者
Sung, J [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Inst Digest Dis, Shatin, Hong Kong, Peoples R China
来源
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2006年 / 3卷 / 01期
关键词
endoscopic hemostasis; proton-pump inhibitor; recurrent bleeding; risk assessment; ulcer bleeding;
D O I
10.1038/ncpgasthep0388
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Peptic ulcer bleeding is a common and potentially fatal condition. It is best managed using a multidisciplinary approach by a team with medical, endoscopic and surgical expertise. The management of peptic ulcer bleeding has been revolutionized in the past two decades with the advent of effective endoscopic hemostasis and potent acid-suppressing agents. A prompt initial clinical and endoscopic assessment should allow patients to be triaged effectively into those who require active therapy, versus those who require monitoring and preventative therapy. A combination of pharmacologic and endoscopic therapy (using a combination of injection and thermal coagulation) offers the best chance of hemostasis for those with active bleeding ulcers. Surgery, being the most effective way to control bleeding, should be considered for treatment failures. The choice between surgery and repeat endoscopic therapy should be based on the pre-existing comorbidities of the patient and the characteristics of the ulcer.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 44 条
[1]  
Adler DG, 2004, GASTROINTEST ENDOSC, V60, P497
[2]  
Barkun A, 2004, GASTROENTEROLOGY, V126, pA78
[3]   Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding [J].
Barkun, A ;
Bardou, M ;
Marshall, JK .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (10) :843-857
[4]   A risk score to predict need for treatment for upper-gastrointestinal haemorrhage [J].
Blatchford, O ;
Murray, WR ;
Blatchford, M .
LANCET, 2000, 356 (9238) :1318-1321
[5]   Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy [J].
Bleau, BL ;
Gostout, CJ ;
Sherman, KE ;
Shaw, MJ ;
Harford, WV ;
Keate, RF ;
Bracy, WP ;
Fleischer, DE .
GASTROINTESTINAL ENDOSCOPY, 2002, 56 (01) :1-6
[6]   Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers [J].
Calvet, X ;
Vergara, M ;
Brullet, E ;
Gisbert, JP ;
Campo, R .
GASTROENTEROLOGY, 2004, 126 (02) :441-450
[7]   Randomized controlled trial comparing epinephrine injection plus heat probe coagulation versus epinephrine injection plus argon plasma coagulation for bleeding peptic ulcers [J].
Chau, CH ;
Siu, WT ;
Law, BKB ;
Tang, CN ;
Kwok, SY ;
Luk, YW ;
Lao, WC ;
Li, MKW .
GASTROINTESTINAL ENDOSCOPY, 2003, 57 (04) :455-461
[8]   The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses [J].
Cheng, HC ;
Kao, AW ;
Chuang, CH ;
Sheu, BS .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (07) :1194-1201
[9]   Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial [J].
Chiu, PWY ;
Lam, CYW ;
Lee, SW ;
Kwong, KH ;
Lam, SH ;
Lee, DTY ;
Kwok, SPY .
GUT, 2003, 52 (10) :1403-1407
[10]   Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers [J].
Chung, SSC ;
Lau, JYW ;
Sung, JJY ;
Chan, ACW ;
Lai, CW ;
Ng, EKW ;
Chan, FKL ;
Yung, MY ;
Li, AKC .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 314 (7090) :1307-1311